Канал: Houston Shock Symposium

Percutaneous Management of Post-MI Complications

Percutaneous Management of Post-MI Complications

STEMI Shock

STEMI Shock

Current Strategies -Potentially Optimizing Outcomes in STEMI Patients Presenting Cardiogenic Shock

Current Strategies -Potentially Optimizing Outcomes in STEMI Patients Presenting Cardiogenic Shock

Protected PCI: Watchful Waiting is the Way to Go- A Device Should be on Standby Only

Protected PCI: Watchful Waiting is the Way to Go- A Device Should be on Standby Only

Protected PCI: Watchful Waiting is Wishful Thinking- A Device Should be Placed Prior to Intervention

Protected PCI: Watchful Waiting is Wishful Thinking- A Device Should be Placed Prior to Intervention

Keynote Address: Randomized Trials in Cardiogenic Shock: Prelude to RECOVER IV

Keynote Address: Randomized Trials in Cardiogenic Shock: Prelude to RECOVER IV

Management of Non-Cardiac, Non-Neurological Consequences on MCS

Management of Non-Cardiac, Non-Neurological Consequences on MCS

MCS with a Salvageable CNS Event

MCS with a Salvageable CNS Event

Markers of Increased LV Loading in VA-ECMO- When to Unload

Markers of Increased LV Loading in VA-ECMO- When to Unload

Navigating the Congenital Heart in Cardiac ICU

Navigating the Congenital Heart in Cardiac ICU

ASH CRASH- When HCM Patient Presents in Shock

ASH CRASH- When HCM Patient Presents in Shock

Does Obesity Paradox Exist in Cardiogenic Shock?

Does Obesity Paradox Exist in Cardiogenic Shock?

Updated Cardiogenic Shock Classification

Updated Cardiogenic Shock Classification

Approach to Severe Stable CAD in Cardiogenic Shock: Should Revascularization be Offered at All?

Approach to Severe Stable CAD in Cardiogenic Shock: Should Revascularization be Offered at All?

Debate: Against- Should Cardiac Arrest be Included into Cardiogenic Shock Staging

Debate: Against- Should Cardiac Arrest be Included into Cardiogenic Shock Staging

Debate: For- Should Cardiac Arrest be Included into Cardiogenic Shock Staging

Debate: For- Should Cardiac Arrest be Included into Cardiogenic Shock Staging

Evaluation and Management of Mitral Regurgitation in Acute Heart Failure

Evaluation and Management of Mitral Regurgitation in Acute Heart Failure

Cardiogenic Shock in Severe AS Patient

Cardiogenic Shock in Severe AS Patient

The Use of LAVA ECMO as a Bridge to Therapy for AR Cardiogenic Shock

The Use of LAVA ECMO as a Bridge to Therapy for AR Cardiogenic Shock

Debate: Post-LVAD Right Ventricular Failure- Late MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Late MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Early MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Early MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Percutaneous MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Percutaneous MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Surgical MCS Support is Best

Debate: Post-LVAD Right Ventricular Failure- Surgical MCS Support is Best

Mixed Shock in a Postpartum Patient

Mixed Shock in a Postpartum Patient

Perfusion Induced Systemic Hyperthermia for Advanced Unresponsive Cancers

Perfusion Induced Systemic Hyperthermia for Advanced Unresponsive Cancers

Microcirculatory Imaging in Medical ICU

Microcirculatory Imaging in Medical ICU

Novel Treatments to Prevent Muscle Wasting in Shock Patients

Novel Treatments to Prevent Muscle Wasting in Shock Patients

Role of ECMO in Septic Shock

Role of ECMO in Septic Shock

Steroids, Thiamine, Vitamin C, Angiotensin II in Shock- When and Why

Steroids, Thiamine, Vitamin C, Angiotensin II in Shock- When and Why

Intravenous Fluids in Septic Shock- Liberal vs. Restrictive

Intravenous Fluids in Septic Shock- Liberal vs. Restrictive

E-CPR- Should it be offered in OHCA?

E-CPR- Should it be offered in OHCA?

The Art of Publishing Sound Clinical Trials

The Art of Publishing Sound Clinical Trials

Non-Cardiogenic Shock Pharmacotherapies: The Standard of Care in 2023

Non-Cardiogenic Shock Pharmacotherapies: The Standard of Care in 2023

Cardiogenic Shock Pharmacotherapies Pearls

Cardiogenic Shock Pharmacotherapies Pearls

Basic Hemodynamics and Phenotypes of Shock

Basic Hemodynamics and Phenotypes of Shock

Opening Remarks

Opening Remarks

Primary Graft Dysfunction

Primary Graft Dysfunction

Low Flow Low Gradient Aortic Stenosis: Who Benefits from TAVR, Who Doesn't?

Low Flow Low Gradient Aortic Stenosis: Who Benefits from TAVR, Who Doesn't?

Ventricular Arrhythmias in Patients with Left Ventricular Assist Device

Ventricular Arrhythmias in Patients with Left Ventricular Assist Device

My Hemodynamic Markers Failed Me!

My Hemodynamic Markers Failed Me!

Shock in Pregnancy

Shock in Pregnancy

One "Two" Many Complications of A Myocardial Infarction

One "Two" Many Complications of A Myocardial Infarction

Deep Cardio. Shock w/Torrential Aortic Insufficiency Stabilized w/ECPELLA as Bridge to AVR Root Surg

Deep Cardio. Shock w/Torrential Aortic Insufficiency Stabilized w/ECPELLA as Bridge to AVR Root Surg

Sliding Towards Extremis

Sliding Towards Extremis

Peri-Procedural AMI In Hospital Cardiac Arrest

Peri-Procedural AMI In Hospital Cardiac Arrest

Novel Therapies in AMI Shock

Novel Therapies in AMI Shock

Sick Heart

Sick Heart

AMI Complicated by VSD & Shock

AMI Complicated by VSD & Shock

Peri-AMI VSD pMCS Choices

Peri-AMI VSD pMCS Choices

Emergent Cannulations, Decannulation, & Navigating ECMO Complications: A Challenging Case

Emergent Cannulations, Decannulation, & Navigating ECMO Complications: A Challenging Case

Role of ECMO in LV Conditioning after Lung Transplantation

Role of ECMO in LV Conditioning after Lung Transplantation

What to do When Right is Really Wrong?

What to do When Right is Really Wrong?

A Case of Profound Vasoplegia post CABG

A Case of Profound Vasoplegia post CABG

Resuscitated Cardiogenic Shock in pMCS- When and How to Wean Devices

Resuscitated Cardiogenic Shock in pMCS- When and How to Wean Devices

Role of Imaging in pMCS Device Weaning

Role of Imaging in pMCS Device Weaning

IABP in Shock: Do Kinetics Differ based on cannulation Strategy?

IABP in Shock: Do Kinetics Differ based on cannulation Strategy?

The Kinetics of Shock in HFpEF: How to Manage

The Kinetics of Shock in HFpEF: How to Manage

Micro-Circulation vs. Macro-Circulation in Cardiogenic Shock

Micro-Circulation vs. Macro-Circulation in Cardiogenic Shock

Slow & Steady Increase in pMCS? Role of Hemodynamic Based Up titration of Support in Cardio. Shock

Slow & Steady Increase in pMCS? Role of Hemodynamic Based Up titration of Support in Cardio. Shock

Go Big or Go Home? Role of Full pMCS in Cardiogenic Shock

Go Big or Go Home? Role of Full pMCS in Cardiogenic Shock

Early Unloading in VA ECMO Shock: When, How, Where, and Why.

Early Unloading in VA ECMO Shock: When, How, Where, and Why.

Revascularization of Cardiogenic Shock; Culprit Lesion Location and Outcomes

Revascularization of Cardiogenic Shock; Culprit Lesion Location and Outcomes

Revascularization in Cardiogenic Shock; Residual Syntax Score and CTOs

Revascularization in Cardiogenic Shock; Residual Syntax Score and CTOs

Role of Hypothermia in Cardiogenic Shock

Role of Hypothermia in Cardiogenic Shock

Why Is Epinephrine Not the Drug of Choice in Cardiogenic Shock

Why Is Epinephrine Not the Drug of Choice in Cardiogenic Shock

ECMO Utilization in COVID-19 ARDS

ECMO Utilization in COVID-19 ARDS

RVAD Support in COVID-19 Induced RV Failure

RVAD Support in COVID-19 Induced RV Failure

COVID-19 ARDS Induced Right Ventricular Failure

COVID-19 ARDS Induced Right Ventricular Failure

VSD Following ACS Shock- Use of pMCS as a Bridge to Repair

VSD Following ACS Shock- Use of pMCS as a Bridge to Repair

Revascularization and Unloading in AMI Shock

Revascularization and Unloading in AMI Shock

SIMPL: Immediate Feedback Loop for Effective Medical Education

SIMPL: Immediate Feedback Loop for Effective Medical Education

Hemodynamics of prolonged pMCS Support- When Vasodilatation Sets

Hemodynamics of prolonged pMCS Support- When Vasodilatation Sets

Utility of pMCS Devices in Valvular Shock?

Utility of pMCS Devices in Valvular Shock?

Severe Aortic Stenosis Management- Early pMCS vs. Emergent TAVR

Severe Aortic Stenosis Management- Early pMCS vs. Emergent TAVR

Case Presentation: Valvular Shock Hemodynamics

Case Presentation: Valvular Shock Hemodynamics

Surviving Sepsis Campaign- Strategies to Implement in Cardiogenic Shock Management

Surviving Sepsis Campaign- Strategies to Implement in Cardiogenic Shock Management

PV Loops in Shock Management: Bench or Bedside?

PV Loops in Shock Management: Bench or Bedside?

Role of Invasive Hemodynamics in Shock Management: Is a PA Catheter always Necessary?

Role of Invasive Hemodynamics in Shock Management: Is a PA Catheter always Necessary?

Hemodynamic Goals in Shock Management: Is there one target for all?

Hemodynamic Goals in Shock Management: Is there one target for all?

Case Presentation: Normotensive Cardiogenic Shock in the Cath Lab

Case Presentation: Normotensive Cardiogenic Shock in the Cath Lab

Hemodynamic Phenotypes of Cardiogenic Shock

Hemodynamic Phenotypes of Cardiogenic Shock

Reperfusion Strategies after Cardiac Arrest

Reperfusion Strategies after Cardiac Arrest

Reperfusion Injury in AMI Shock- Role of pMCS Devices

Reperfusion Injury in AMI Shock- Role of pMCS Devices

Should All Shock Centers Offer E-CPR? Balancing Futility Cost Effectiveness and Hope

Should All Shock Centers Offer E-CPR? Balancing Futility Cost Effectiveness and Hope

SCAI Classification of Shock Severity- What is Missing?

SCAI Classification of Shock Severity- What is Missing?

Pitfalls in Assessment of Cardiogenic Shock Severity

Pitfalls in Assessment of Cardiogenic Shock Severity

Role of pMCS in Hemo-Metabolic Shock

Role of pMCS in Hemo-Metabolic Shock

Racial Variations in Shock Presentation and Outcomes

Racial Variations in Shock Presentation and Outcomes

Challenges of Cardiogenic Shock Clinical Trials

Challenges of Cardiogenic Shock Clinical Trials

Where Are the Cardiogenic Shock Guidelines?

Where Are the Cardiogenic Shock Guidelines?

Houston Shock Sympoisum 2020

Houston Shock Sympoisum 2020

Session 1: Managing Cardio-Metabolic Syndrome in ICU:Ventilation,Nutrition,&Multi-Organ Dysfunction

Session 1: Managing Cardio-Metabolic Syndrome in ICU:Ventilation,Nutrition,&Multi-Organ Dysfunction

Session 1: Managing the Crashing Patient in the ICU: Pressors & Inotropes.

Session 1: Managing the Crashing Patient in the ICU: Pressors & Inotropes.

Session 2: The Optimal Support Platform in Shock: Let's Not Forget the IABP.

Session 2: The Optimal Support Platform in Shock: Let's Not Forget the IABP.

Session 2: Rotodynamic Pumps: Impella and TandemHeart

Session 2: Rotodynamic Pumps: Impella and TandemHeart

Session 2: Markers of Adequate Resuscitation in Cardiogenic Shock

Session 2: Markers of Adequate Resuscitation in Cardiogenic Shock

Session 1: Cardiogenic Shock: The Scope of the Problem

Session 1: Cardiogenic Shock: The Scope of the Problem

Session 1: Hemodynamics of Cardiogenic Shock

Session 1: Hemodynamics of Cardiogenic Shock

Session 2: ECMO for Cardiogenic Shock

Session 2: ECMO for Cardiogenic Shock

Session 7: Obstructive Cardiogenic shock in the Era of Percutaneous Valve Therapies.

Session 7: Obstructive Cardiogenic shock in the Era of Percutaneous Valve Therapies.

Session 3: The Stages of Cardiogenic Shock

Session 3: The Stages of Cardiogenic Shock

Session 6: Molecular Signature of Cardiogenic Shock

Session 6: Molecular Signature of Cardiogenic Shock

Session 6: Beyond Blood Pressure and Lactate Levels: Perfusion Endpoints in Shock

Session 6: Beyond Blood Pressure and Lactate Levels: Perfusion Endpoints in Shock

Session 5: Percutaneous MCS Devices PV Loops in Shock Impurities from the Bedside.

Session 5: Percutaneous MCS Devices PV Loops in Shock Impurities from the Bedside.

Session 5: Percutaneous MCS Devices: PV Loops in Shock: A Purist Perspective

Session 5: Percutaneous MCS Devices: PV Loops in Shock: A Purist Perspective

Session 4: Cardiogenic Shock Cost Effectiveness

Session 4: Cardiogenic Shock Cost Effectiveness

Session 3: Shortcomings of Current Cardiogenic Shock Definition.

Session 3: Shortcomings of Current Cardiogenic Shock Definition.

Session 6: Predicting Fluid Responsiveness in Cardiogenic Shock

Session 6: Predicting Fluid Responsiveness in Cardiogenic Shock

Session 7: Cardiogenic Shock in "HFpEF" Patients.

Session 7: Cardiogenic Shock in "HFpEF" Patients.

Session 6: From a Pressure-Driven to a Perfusion-Centered Resuscitation Strategy

Session 6: From a Pressure-Driven to a Perfusion-Centered Resuscitation Strategy

Session 5: Invasive Hemodynamic Monitoring is not Mandatory in pMCS Supported Shock Patients.

Session 5: Invasive Hemodynamic Monitoring is not Mandatory in pMCS Supported Shock Patients.

Session 7: Ablative Therapies in the Electrically Unstable Patients

Session 7: Ablative Therapies in the Electrically Unstable Patients

Houston Shock Symposium Opening Remarks

Houston Shock Symposium Opening Remarks

Session 7: Should we VAD pMCS supported patients in Era of New Allocation System

Session 7: Should we VAD pMCS supported patients in Era of New Allocation System

Session 6: Should Absolute Blood Pressure Measurement be a Target in Cardiogenic Shock Management?

Session 6: Should Absolute Blood Pressure Measurement be a Target in Cardiogenic Shock Management?

Session 7: The Dark side of pMCS in the ICU: The Patient with no Exit Strategy

Session 7: The Dark side of pMCS in the ICU: The Patient with no Exit Strategy

Session 6: Echocardiographic Parameters of Cardiogenic Shock Recovery

Session 6: Echocardiographic Parameters of Cardiogenic Shock Recovery

Session 5: Unloading in VA-ECMO supported Patients is always needed

Session 5: Unloading in VA-ECMO supported Patients is always needed

Session 4: National Cardiogenic Shock Initiative

Session 4: National Cardiogenic Shock Initiative

Session 3: Pathophysiology of Cardiogenic Shock

Session 3: Pathophysiology of Cardiogenic Shock

Session 4: The Decade in Review: Current State of Cardiogenic Shock Trials

Session 4: The Decade in Review: Current State of Cardiogenic Shock Trials

Session 7: Revascularization of multi-vessel disease in AMI Cardiogenic Shock

Session 7: Revascularization of multi-vessel disease in AMI Cardiogenic Shock

Session 3: SHOCK Severity Scores: SHOCK, ORBI, GRACE, and beyond

Session 3: SHOCK Severity Scores: SHOCK, ORBI, GRACE, and beyond

Session 9: Takotsubo Cardiogenic Shock

Session 9: Takotsubo Cardiogenic Shock

Session 9: Right Ventricular Failure in Acute Myocarditis: Upfront or Bailout Straegy

Session 9: Right Ventricular Failure in Acute Myocarditis: Upfront or Bailout Straegy

Session 8: Cardiogenic Shock: When “A” to “E” Is a Blur.

Session 8: Cardiogenic Shock: When “A” to “E” Is a Blur.

Session 9: pMCS Bridging in Fulminant Myocarditis

Session 9: pMCS Bridging in Fulminant Myocarditis

Session 9: Postoperative Cardiogenic Shock after Coronary Dissection – A Story of Persistence

Session 9: Postoperative Cardiogenic Shock after Coronary Dissection – A Story of Persistence

Session 9: Christmas Worst Nightmare to a Precious New Year’s Gift

Session 9: Christmas Worst Nightmare to a Precious New Year’s Gift

Session 8: No Easy Answers: Cryptogenic Shock, niCM, and 1 month admission!

Session 8: No Easy Answers: Cryptogenic Shock, niCM, and 1 month admission!

Session 9: Flying for Life. A Team Approach.

Session 9: Flying for Life. A Team Approach.

Session 8: Anything That Can Will Go Wrong

Session 8: Anything That Can Will Go Wrong

Session 8: A Transplant Disaster

Session 8: A Transplant Disaster

Session 9: Dynamic Hemodynamic Collapse

Session 9: Dynamic Hemodynamic Collapse

Session 9: When VA ECMO Is Not Enough For Acute On Chronic Massive PE

Session 9: When VA ECMO Is Not Enough For Acute On Chronic Massive PE

Session 8: Bi-Pella Support in ACS Shock

Session 8: Bi-Pella Support in ACS Shock

Session 8: AMI – CS pMCS Success Story

Session 8: AMI – CS pMCS Success Story

Session 8: Decision Making in ACS Shock

Session 8: Decision Making in ACS Shock

Session 8: Failure of Impella Assisted HR-PCI

Session 8: Failure of Impella Assisted HR-PCI

Session 2: Understanding Exit Strategies in Shock Patients

Session 2: Understanding Exit Strategies in Shock Patients

Session 3: Severity Scoring for CGS: Lessons from APACHE

Session 3: Severity Scoring for CGS: Lessons from APACHE

Session 4: Building a Cardiogenic Shock Team

Session 4: Building a Cardiogenic Shock Team

Session 3: Redefining Cardiogenic Shock Classification

Session 3: Redefining Cardiogenic Shock Classification

Session 4: The Furture of Cardiovascular Care and The Challenge of Trials in Shock

Session 4: The Furture of Cardiovascular Care and The Challenge of Trials in Shock

Session 4: Myocardial Remission in the Failing Heart

Session 4: Myocardial Remission in the Failing Heart

Session 5: Unloading in VA-ECMO Supported Patients is Not Always Needed

Session 5: Unloading in VA-ECMO Supported Patients is Not Always Needed

The Role of LV Unloading in Acute Ischemic Shock: From the Bench to the Bedside

The Role of LV Unloading in Acute Ischemic Shock: From the Bench to the Bedside

A Complex STEMI with MV Disease and Shock

A Complex STEMI with MV Disease and Shock

VA ECMO: A Little Too Late?

VA ECMO: A Little Too Late?

Mitral and Tricuspid Clip in Cardiogenic Shock

Mitral and Tricuspid Clip in Cardiogenic Shock

Advantages of Impella 5.0 as a Bridge to LVAD Therapy: A Surgeon's Perspective.

Advantages of Impella 5.0 as a Bridge to LVAD Therapy: A Surgeon's Perspective.

VV ECMO Utilization in Hypoxic Trauma Patients.

VV ECMO Utilization in Hypoxic Trauma Patients.

Reversing Metabolic Pathways in Advanced Heart Failure and Shock.

Reversing Metabolic Pathways in Advanced Heart Failure and Shock.

Minimizing SIRS Response to Device Therapies from a Biomedical Engineering Perspective.

Minimizing SIRS Response to Device Therapies from a Biomedical Engineering Perspective.

Do Pediatrics Respond Differently to Device Therapies than Adults?

Do Pediatrics Respond Differently to Device Therapies than Adults?

Blood- Device Interaction in the Shock State.

Blood- Device Interaction in the Shock State.

The Economics of Cardiogenic Shock Management.

The Economics of Cardiogenic Shock Management.

Designing the Ideal Contemporary Cardiogenic Shock Trial

Designing the Ideal Contemporary Cardiogenic Shock Trial

Post Cardiotomy Shock: Best Exit Strategies in the OR.

Post Cardiotomy Shock: Best Exit Strategies in the OR.

When My VA ECMO Supported Patient is Still Hypotensive and Hypoxic

When My VA ECMO Supported Patient is Still Hypotensive and Hypoxic

Continuous Low Flow Alarms and Hypotension Following LVAD Implantation

Continuous Low Flow Alarms and Hypotension Following LVAD Implantation

Post Cardiac Transplant Shock- Optimal Therapies for Severe PGD

Post Cardiac Transplant Shock- Optimal Therapies for Severe PGD

Adjunct Pharmacotherapies in Device Supported Patients: Does Drug Class Matter?

Adjunct Pharmacotherapies in Device Supported Patients: Does Drug Class Matter?

A Storm is Brewing

A Storm is Brewing

Medical Management of VT Storm in Shock

Medical Management of VT Storm in Shock

Ablative Therapies of VT Storm in Shock

Ablative Therapies of VT Storm in Shock

Hemodynamically Unstable Massive Pulmonary Embolism

Hemodynamically Unstable Massive Pulmonary Embolism

A 31-year-old with Bad Luck

A 31-year-old with Bad Luck

Bi-Pella Support in Thyroid Cardiomyopathy

Bi-Pella Support in Thyroid Cardiomyopathy

A Unique Case of Cardiomyopathy with BiV Support.

A Unique Case of Cardiomyopathy with BiV Support.

An Uncommon Cause of AMI Shock

An Uncommon Cause of AMI Shock

Impella 5.0 Interaction with Mitral Valve Apparatus

Impella 5.0 Interaction with Mitral Valve Apparatus

Impella Support is not Always Straight Forward

Impella Support is not Always Straight Forward

Embolisms with TandemHeart Support

Embolisms with TandemHeart Support

VA-ECMO: Limb Ischemia

VA-ECMO: Limb Ischemia

A Rare Complication of VA- ECMO

A Rare Complication of VA- ECMO

Pre-Hospital EMS Management of Cardiogenic Shock

Pre-Hospital EMS Management of Cardiogenic Shock

Cardiogenic Shock Initiative

Cardiogenic Shock Initiative

Regionalizing Shock Care: Sessions from Trauma, Stroke, and Myocardial Infarction

Regionalizing Shock Care: Sessions from Trauma, Stroke, and Myocardial Infarction

Non-Device, Non-Pharmacologic Therapies in the Critically Ill Patient

Non-Device, Non-Pharmacologic Therapies in the Critically Ill Patient